These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6287200)

  • 41. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Conformation of acetylcholine and its amide analogs during interaction with nicotinic cholinoreceptors].
    Khromov-Borisov NV; Danilov AF; Brovtsyna NB; Aleksandrova LN; Indenbom ML
    Dokl Akad Nauk SSSR; 1976; 230(5):1250-3. PubMed ID: 1087602
    [No Abstract]   [Full Text] [Related]  

  • 43. Cholinolytic action of phencyclidine derivatives.
    Paster Z; Maayani S; Weinstein H; Sokolovsky M
    Eur J Pharmacol; 1974 Feb; 25(2):270-4. PubMed ID: 4435032
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of ethidium bromide on the nicotinic acetylcholine receptor.
    Sterz R; Hermes M; Peper K; Bradley RJ
    Eur J Pharmacol; 1982 Jun; 80(4):393-9. PubMed ID: 6286326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biogenic antagonists of the nicotinic receptor: their interactions with erabutoxin.
    Koketsu K; Akasu T; Miyagawa M; Hirai K
    Brain Res; 1982 Nov; 250(2):391-3. PubMed ID: 6293646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and properties of phencyclidine-binding sites in nervous tissues.
    Vincent JP; Bidard JN; Lazdunski M; Romey G; Tourneur Y; Vignon J
    Fed Proc; 1983 Jun; 42(9):2570-3. PubMed ID: 6303860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Voltage dependencies of the effects of chlorpromazine on the nicotinic receptor channel from mouse muscle cell line So18.
    Benoit P; Changeux JP
    Neurosci Lett; 1993 Sep; 160(1):81-4. PubMed ID: 7504221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histrionicotoxins: effects on binding of radioligands for sodium, potassium, and calcium channels in brain membranes.
    Lovenberg T; Daly JW
    Neurochem Res; 1986 Nov; 11(11):1609-21. PubMed ID: 2446155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
    Souccar C; Varanda WA; Aronstam RS; Daly JW; Albuquerque EX
    Mol Pharmacol; 1984 May; 25(3):395-400. PubMed ID: 6328265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and behavioral activity of cis-4-phenyl, 4-piperidinocyclohexanol, a metabolite of phencyclidine.
    Martin BR; Vincek WC; Balster RL
    Subst Alcohol Actions Misuse; 1981; 2(3):143-7. PubMed ID: 7313923
    [No Abstract]   [Full Text] [Related]  

  • 51. Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors.
    Gabrielevitz A; Kloog Y; Kalir A; Balderman D; Sokolovsky M
    Life Sci; 1980 Jan; 26(2):89-95. PubMed ID: 7366325
    [No Abstract]   [Full Text] [Related]  

  • 52. Repriming of the delayed potassium channel in frog skeletal muscle.
    Argibay JA
    Acta Cient Venez; 1980; 31(4):324-30. PubMed ID: 6269339
    [No Abstract]   [Full Text] [Related]  

  • 53. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
    Reitstetter R; Lukas RJ; Gruener R
    J Pharmacol Exp Ther; 1999 May; 289(2):656-60. PubMed ID: 10215636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroreceptors and ion channels as the basis for drug action: past, present, and future.
    Narahashi T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):1-26. PubMed ID: 10871290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of sodium bisulphite on nicotinic cholinoceptors in the frog rectus abdominis muscle.
    Watson SP; Gulliver PA
    Biochem Pharmacol; 1981 Feb; 30(4):395-7. PubMed ID: 6971099
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of physostigmine on the excitation-contraction coupling of skeletal muscle fibres.
    Szücs G; Fuxreiter M; Sirkó E; Szállási A
    Acta Physiol Hung; 1983; 62(1):61-73. PubMed ID: 6316729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the effect of pentacaine on membrane and contractile properties of muscle fibers with sodium and calcium electrogenesis].
    Zacharová D; Lipskaja E; Hencek M; Zachar A; Záhorec R
    Bratisl Lek Listy; 1985 Oct; 84(4):385-96. PubMed ID: 2415222
    [No Abstract]   [Full Text] [Related]  

  • 60. Experiments with photoisomerizable molecules at nicotinic acetylcholine receptors in cells and membrane patches from rat muscle.
    Lester HA; Chabala LD; Gurney AM; Sheridan RE
    Soc Gen Physiol Ser; 1986; 40():447-62. PubMed ID: 2424099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.